217 related articles for article (PubMed ID: 27320908)
1. Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer.
McLoed AG; Sherrill TP; Cheng DS; Han W; Saxon JA; Gleaves LA; Wu P; Polosukhin VV; Karin M; Yull FE; Stathopoulos GT; Georgoulias V; Zaynagetdinov R; Blackwell TS
Cell Rep; 2016 Jun; 16(1):120-132. PubMed ID: 27320908
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.
Greten FR; Arkan MC; Bollrath J; Hsu LC; Goode J; Miething C; Göktuna SI; Neuenhahn M; Fierer J; Paxian S; Van Rooijen N; Xu Y; O'Cain T; Jaffee BB; Busch DH; Duyster J; Schmid RM; Eckmann L; Karin M
Cell; 2007 Sep; 130(5):918-31. PubMed ID: 17803913
[TBL] [Abstract][Full Text] [Related]
3. Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.
Enzler T; Sano Y; Choo MK; Cottam HB; Karin M; Tsao H; Park JM
Cancer Discov; 2011 Nov; 1(6):496-507. PubMed ID: 22389871
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.
Karabela SP; Psallidas I; Sherrill TP; Kairi CA; Zaynagetdinov R; Cheng DS; Vassiliou S; McMahon F; Gleaves LA; Han W; Stathopoulos I; Zakynthinos SG; Yull FE; Roussos C; Kalomenidis I; Blackwell TS; Stathopoulos GT
Carcinogenesis; 2012 Apr; 33(4):859-67. PubMed ID: 22287559
[TBL] [Abstract][Full Text] [Related]
5. Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma.
Xue W; Meylan E; Oliver TG; Feldser DM; Winslow MM; Bronson R; Jacks T
Cancer Discov; 2011 Aug; 1(3):236-47. PubMed ID: 21874163
[TBL] [Abstract][Full Text] [Related]
6. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
8. Ethanol Decreases Inflammatory Response in Human Lung Epithelial Cells by Inhibiting the Canonical NF-kB-Pathway.
Mörs K; Hörauf JA; Kany S; Wagner N; Sturm R; Woschek M; Perl M; Marzi I; Relja B
Cell Physiol Biochem; 2017; 43(1):17-30. PubMed ID: 28848184
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of interleukin 1β-stimulated interleukin-6 production by cranberry components in human gingival epithelial cells: effects on nuclear factor κB and activator protein 1 activation pathways.
Tipton DA; Carter TB; Dabbous MKh
J Periodontal Res; 2014 Aug; 49(4):437-47. PubMed ID: 23952046
[TBL] [Abstract][Full Text] [Related]
10. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
Yao F; Zhou W; Zhong C; Fang W
Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
[TBL] [Abstract][Full Text] [Related]
11. Effects of the NF-κB Pathway Agonist IL-1β on Non-Small Cell Lung Cancer Cell Lines.
Liu D; Liu XQ; Kiefl R; Zhang W; Xu YH; Tufman A
Ann Clin Lab Sci; 2021 May; 51(3):295-301. PubMed ID: 34162558
[TBL] [Abstract][Full Text] [Related]
12. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
13. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
Karthik S; Sankar R; Varunkumar K; Anusha C; Ravikumar V
Biomed Pharmacother; 2015 Feb; 69():337-44. PubMed ID: 25661379
[TBL] [Abstract][Full Text] [Related]
14. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.
Shishodia S; Potdar P; Gairola CG; Aggarwal BB
Carcinogenesis; 2003 Jul; 24(7):1269-79. PubMed ID: 12807725
[TBL] [Abstract][Full Text] [Related]
15. Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling.
Muselet-Charlier C; Roque T; Boncoeur E; Chadelat K; Clement A; Jacquot J; Tabary O
Biochem Biophys Res Commun; 2007 Jun; 357(2):402-7. PubMed ID: 17420005
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
18. A Polyphenol-rich Pomegranate Fruit Extract Suppresses NF-κB and IL-6 Expression by Blocking the Activation of IKKβ and NIK in Primary Human Chondrocytes.
Haseeb A; Khan NM; Ashruf OS; Haqqi TM
Phytother Res; 2017 May; 31(5):778-782. PubMed ID: 28276100
[TBL] [Abstract][Full Text] [Related]
19. CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell.
Wang X; Jiang CM; Wan HY; Wu JL; Quan WQ; Bals R; Wu KY; Li D
PLoS One; 2012; 7(12):e52117. PubMed ID: 23284890
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts.
Chi PL; Luo SF; Hsieh HL; Lee IT; Hsiao LD; Chen YL; Yang CM
Arthritis Rheum; 2011 Oct; 63(10):2905-17. PubMed ID: 21702012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
